Trustar Capital acquires Chinese throat medicine maker Guilong Pharmaceutical

Trustar Capital acquires Chinese throat medicine maker Guilong Pharmaceutical

Joymitra Rai

02 April, 2024

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter
Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2026 All rights reserved.